What does CH stand for?
Suggest new definition
This definition appears very rarely
and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other meanings of CH
We have 75 other definitions for CH
in our Acronym Attic
Samples in periodicals archive:
NASDAQ:IDIX), Cambridge, Mass, has announced that the Swissmedic has approved telbivudine as a new treatment for chronic hepatitis
B (CHB) in compensated patients with evidence of viral replication and active liver inflammation.
May 15 /PRNewswire/ -- Today, the Hepatitis B Foundation and Bristol-Myers Squibb Company announced the launch of the third-annual "AIM for the B: Awareness, Involvement and Mobilization for Chronic Hepatitis
B" program, a public education initiative designed to elevate awareness of chronic hepatitis
B as a serious health issue in the United States and emphasize the importance of disease management, especially among Asian Americans who are disproportionately affected with the disease.
BASEL, Switzerland, January 21 /PRNewswire/ -- - First pegylated interferon to be indicated for treating chronic hepatitis
B Roche announced today that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for PEGASYS(R) (peginterferon alfa-2a (40KD)) for the treatment of chronic hepatitis
In the other approach, based on growing evidence that the development and persistence of chronic hepatitis
B infection may be caused by insufficient production of alpha interferon by white blood cells called lymphocytes, researchers use the interferon itself -- a small protein made by cells as a defense against viral infection and produced in quantity by laboratory recombinant techniques.
STOCKHOLM, Sweden -- Medivir, on behalf of the Tibotec and Medivir collaborative project, announced that this week Tibotec initiated a phase I clinical trial with a potent and selective hepatitis C virus (HCV) NS3/4A protease inhibitor, for the treatment of chronic hepatitis
C virus infection.
Celgosivir is an orally administered, first-in-class alpha glucosidase 1 inhibitor, in development for the treatment of chronic hepatitis
C virus (HCV) infections.
May 9 /PRNewswire/ -- In recognition of the need to increase education and awareness for chronic hepatitis
B, the Hepatitis B Foundation and Bristol-Myers Squibb Company are partnering to host "AIM for the B: Awareness, Involvement and Mobilization for Chronic Hepatitis
B," a public education program designed to elevate the urgency for prioritizing chronic hepatitis
B as a serious health issue in the United States.
These results were achieved in chronic hepatitis
C patients infected with the difficult-to-treat genotype 1 virus.